IMI Offers €12m For Patient Engagement Project
This article was originally published in The Pink Sheet Daily
Executive Summary
Five-year project aims to support development of guidance for industry, regulators on when how and when to factor in patient perspectives on drug benefits and risks.
You may also be interested in...
How Patients Are Transforming Pharma R&D
Patient-centric R&D is imperative for pharma in delivering effective medicines and better outcomes. The push to implement it is challenging long-held biopharma business practices, including how clinical trials are designed, recruited and run – and what they measure.
Clinical Pathway Development Lacks Patient Input, White Paper Says
PhRMA says the finding that patients' views are not considered when providers and payers develop pathways to standardize treatment, most commonly in oncology, is "eye opening."
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.